Thomas Weisel Partners Thermo Fisher Strengthens PCR Portfolio with $260M Fermentas Acquisition Premium Thomas Weisel Partners called Thermo Fisher's planned $260 million acquisition of Fermentas a "synergistic tuck-in deal" that "bolsters Thermo's capabilities in the high-growth PCR market." Cepheid Shares Downgraded by Bank An investment analyst downgraded the shares to "market perform," citing the current hospital spending environment. Bank Ups 2010 Revenue, EPS Estimates for Waters The investment bank upped its estimates for the firm, citing a recent meeting with executives who said that they continue to see a stabilization in end markets. Helicos Cuts Q3 Net Loss by Almost 40 Percent; Rules out Potential Sale of Company Helicos said that based on its "improving standalone prospects and current market valuation" that it has disengaged from discussions involving a potential sale of the company. Majority of Proteomic Stimulus Winners Not Likely to Buy Equipment, Analyst Report Finds Premium A Thomas Weisel Partners report found that some researchers do not plan to use the stimulus cash to buy equipment, such as mass specs. Rather, a majority said they would use the cash to hire additional personnel. Apr 8, 2009 Investment Bank Reports Advantage of CLIA Labs in Driving Adoption of OncotypeDX Premium Apr 3, 2009 Analyst Sees Stimulus Countering Funding Weakness Late in '09 Feb 27, 2009 Beckman Coulter to Issue $500M in New Debt for Olympus Dx Acquisition Feb 6, 2009 Millipore Buys Guava for $22.6M; Aims to Bring Integrated Cell-Analysis Tool to Benchtop Premium Feb 3, 2009 Affy Hopes Rx-Development Apps, New Platform Will Drive Growth After 'Tough' 2008 Premium Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.